| Product Code: ETC4720411 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The human insulin market in Sweden is characterized by a growing demand due to the increasing prevalence of diabetes, driven by aging demographics and lifestyle factors. Technological advancements in insulin delivery systems, including insulin pens and pumps, are boosting market growth. There is also an increasing focus on developing biosimilar insulins to make diabetes treatment more affordable. The market is supported by Swedens strong healthcare infrastructure and government initiatives for chronic disease management.
The drivers of the Sweden human insulin market include the rising prevalence of diabetes, driven by lifestyle changes and an aging population. The governments focus on improving healthcare infrastructure and ensuring access to essential medicines has further boosted the demand for human insulin. Innovations in insulin delivery systems, such as insulin pens and pumps, are also supporting market growth.
The Sweden human insulin market is confronted by high R&D costs, stringent regulations, and pricing pressures from healthcare providers and insurance companies. Furthermore, competition from biosimilar products and the increasing prevalence of alternative treatments contribute to market challenges.
The Swedish government regulates the human insulin market through pricing controls and reimbursement policies under its healthcare system. Efforts are made to ensure the affordability and accessibility of insulin for all citizens. Research and development in biosimilar insulin are encouraged through government grants and public-private partnerships, promoting innovation in diabetes care.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Human Insulin Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Human Insulin Market - Industry Life Cycle |
3.4 Sweden Human Insulin Market - Porter's Five Forces |
3.5 Sweden Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Sweden Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Sweden Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Sweden Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Sweden |
4.2.2 Rising awareness about insulin therapy |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost associated with insulin therapy |
4.3.2 Stringent regulatory requirements for insulin products |
4.3.3 Limited access to healthcare services in certain regions of Sweden |
5 Sweden Human Insulin Market Trends |
6 Sweden Human Insulin Market Segmentations |
6.1 Sweden Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Sweden Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Sweden Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Sweden Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Sweden Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Sweden Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Sweden Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Sweden Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Sweden Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Sweden Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Sweden Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Sweden Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Sweden Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Sweden Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Sweden Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Sweden Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Sweden Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Sweden Human Insulin Market Import-Export Trade Statistics |
7.1 Sweden Human Insulin Market Export to Major Countries |
7.2 Sweden Human Insulin Market Imports from Major Countries |
8 Sweden Human Insulin Market Key Performance Indicators |
8.1 Average age of diabetes diagnosis in Sweden |
8.2 Adoption rate of new insulin delivery technologies |
8.3 Percentage of diabetic population in Sweden using insulin pump therapy |
8.4 Government funding for diabetes research and treatment |
8.5 Number of healthcare facilities offering specialized diabetes care services |
9 Sweden Human Insulin Market - Opportunity Assessment |
9.1 Sweden Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Sweden Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Sweden Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Sweden Human Insulin Market - Competitive Landscape |
10.1 Sweden Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Sweden Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |